Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.


Mar 19, 2018
AHA and other healthcare related organizations stress the importance of congressional action to lower healthcare premiums. 
Mar 16, 2018
AHA letter to Ways and Means Committee regarding policy recommendations to address the opioid epidemic.
Mar 9, 2018
AHA responds to the Centers for Medicare Medicaid Services' request for information on revisions to personnel regulations, proficiency testing (PT) referral, histocompatibility regulations, and fee regulations under the Clinical Laboratory Improvement Amendments (CLIA) of 1988.
Mar 6, 2018
AHA, others urge Congress to move forward with bipartisan legislation to reduce premiums, improve affordability, and improve the individual health insurance market.
Mar 5, 2018
AHA, others express concerns that Anthem’s coverage policies for outpatient imaging and emergency care services are detrimental to patients, diminishing access to care and driving care location based on the lowest cost provider.
Mar 5, 2018
AHA's comment on CMS's 2019 Advance Notice and draft Call Letter for 2019.
Feb 28, 2018
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, and our clinician partners – including more than 270,000 affiliated physicians, 2 million nurses
Feb 27, 2018
The undersigned groups respectfully request that the Drug Enforcement Administration (DEA) adjust aggregate production quotas (APQ) for certain opioids in order to mitigate ongoing drug shortages.